Research shows that neutralizing antibodies which are induced by vaccination can protect animals from HIV infection.
Developing a safe and effective HIV (Human Immunodeficiency Virus)...
Current antibiotics used in clinical practice, in addition to neutralising target pathogens also harm healthy bacteria in the gut. The disturbance in gut microbiome has...
On October 22, 2024, a surgical team performed the first fully robotic double lung transplant on a 57-year-old woman with chronic obstructive pulmonary disease...
Asciminib (Scemblix) has been approved for adult patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in chronic phase (CP). The accelerated approval...
On 11 October 2024, Hympavzi (marstacimab-hncq), a human monoclonal antibody targeting “tissue factor pathway inhibitor” received US FDA’s approval as a new drug for...
BNT116 and LungVax are nucleic acid lung cancer vaccine candidates – the former is based on mRNA technology similar to “COVID-19 mRNA vaccines” such...
Monoclonal antibodies (mAbs) lecanemab and donanemab have been approved for the treatment of early Alzheimer’s disease in the UK and USA respectively while lecanemab...